Contributing Author: Joshua Boyce, M.D.

Sci Immunol. 2021 Dec 24;6(66):eabj0474. doi: 10.1126/sciimmunol.abj0474. Epub 2021 Dec 24. ABSTRACT [Figure: see text]. PMID:34932383 | DOI:10.1126/sciimmunol.abj0474

Sci Immunol. 2021 Feb 26;6(56):eabb7221. doi: 10.1126/sciimmunol.abb7221. ABSTRACT Mast cells (MCs) play a pathobiologic role in type 2 (T2) allergic inflammatory diseases of the airway,

N Engl J Med. 2021 Mar 11;384(10):e37. doi: 10.1056/NEJMc2100766. Epub 2021 Feb 10. NO ABSTRACT PMID:33567190 | DOI:10.1056/NEJMc2100766

N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30. NO ABSTRACT PMID:33378605 | PMC:PMC7787218 | DOI:10.1056/NEJMra2035343

Cell. 2020 May 28;181(5):1016-1035.e19. doi: 10.1016/j.cell.2020.04.035. Epub 2020 Apr 27. ABSTRACT There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome

Allergy. 2020 Apr;75(4):1001-1002. doi: 10.1111/all.14066. Epub 2019 Oct 21. NO ABSTRACT PMID:31560800 | DOI:10.1111/all.14066

Am J Respir Crit Care Med. 2019 Sep 15;200(6):704-711. doi: 10.1164/rccm.201809-1755OC. ABSTRACT Rationale: Daily high-dose aspirin therapy benefits many patients with aspirin-exacerbated respiratory disease but

Nature. 2018 Aug;560(7720):649-654. doi: 10.1038/s41586-018-0449-8. Epub 2018 Aug 22. ABSTRACT Barrier tissue dysfunction is a fundamental feature of chronic human inflammatory diseases1. Specialized subsets of

J Immunol. 2018 Feb 1;200(3):915-927. doi: 10.4049/jimmunol.1700603. Epub 2017 Dec 27. ABSTRACT Cysteinyl leukotrienes (cysLTs) facilitate mucosal type 2 immunopathology by incompletely understood mechanisms. Aspirin-exacerbated

N Engl J Med. 2017 Aug 10;377(6):597. doi: 10.1056/NEJMc1708004. NO ABSTRACT PMID:28813135 | DOI:10.1056/NEJMc1708004